Post-switch Effectiveness of Etanercept Biosimilar Versus Continued Etanercept in Rheumatoid Arthritis Patients with Stable Disease: A Prospective Multinational Observational Study.

Janet E PopeStephen HallClaire BombardierBoulos HaraouiGraeme JonesLatha NaikCarol J EtzelDena R RameyRicardo InfanteMaia MiguelezStephanie FalcaoSevag SahakianDavid Wu

Published in: Advances in therapy (2022)

SB4 demonstrated comparable effectiveness to ETN over 12 months in patients with stable RA who voluntarily switched to the biosimilar in a real-world setting.

Keyphrases

rheumatoid arthritis
ankylosing spondylitis
disease activity
randomized controlled trial
systematic review
rheumatoid arthritis patients
interstitial lung disease
juvenile idiopathic arthritis
systemic sclerosis